In addition, Yeh et al. showed that VEGF-C/VEGFR3-mediated KRAS/YAP1/Slug pathway could be suppressed by treatment with anti-VEGFR3 peptide, leading to the inhibition of migration, invasion, and stemness of skin cancer cells [92] (Figure 3). The gene discussed is VEGFC; the disease is skin cancer.